Share on twitter
Share on LinkedIn
Share on Facebook
Email to a friend
Print page
This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only implants currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK.
This document is up-to-date
This CEU Statement provides guidance to healthcare professionals in response to a letter circulated by MSD (manufacturer of Nexplanon®) to healthcare professionals in the UK about updated guidance regarding the recommended Nexplanon® insertion site.
This document is up-to-date
This summary has been written as a quick reference guide to help busy clinicians to give clear, safe advice on Progestogen-only Implant). Please refer to the full 2018 FSRH Progestogen-only Implant Clinical Guideline for further information and evidence for this advice. This document is written for FSRH members and requires you to log in to access it.
This document is up-to-date
Login to view this document. 1 CPD credit can be claimed for reading the guidance. 1 CPD credit can be claimed for answering the questions.
This document is up-to-date
